综上所述，奥氮平联合止吐在预防乳腺癌新辅助化疗所致的急性和延迟性CINV疗效确切，尤其对延迟性CINV疗效更好，且不良反應轻，值得临床上推广应用。

    [参考文献]

    [1] Rojas C，Slusher BS.Pharmacological mechanisms of 5-HT3 and tachylinin NK-1 receptor antagonism to pre-vent chemotherapy induced nausea and vomiting[J].Eur J Pharmacol.2012 ......